Legal & General Group
HRMY icon

Legal & General Group’s Harmony Biosciences HRMY Stock Holding History

Legal & General Group’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.5M Sell
96,259
-882
-0.9% -$27.8K ﹤0.01% 1737
2026
Q1 		$2.72M Sell
97,141
-10,012
-9% -$328K ﹤0.01% 1785
2025
Q4 		$4.01M Sell
107,153
-5,800
-5% -$191K ﹤0.01% 1680
2025
Q3 		$3.11M Sell
112,953
-1,979
-2% -$68.2K ﹤0.01% 1791
2025
Q2 		$3.63M Buy
114,932
+4,643
+4% +$149K ﹤0.01% 1692
2025
Q1 		$3.66M Sell
110,289
-6,670
-6% -$239K ﹤0.01% 1668
2024
Q4 		$4.02M Buy
116,959
+27,619
+31% +$949K ﹤0.01% 1685
2024
Q3 		$3.57M Sell
89,340
-2,855
-3% -$100K ﹤0.01% 1727
2024
Q2 		$2.78M Sell
92,195
-1,712
-2% -$51.5K ﹤0.01% 1791
2024
Q1 		$3.15M Sell
93,907
-459
-0.5% -$14.7K ﹤0.01% 1732
2023
Q4 		$3.05M Sell
94,366
-4,117
-4% -$115K ﹤0.01% 1744
2023
Q3 		$3.23M Buy
98,483
+9,657
+11% +$335K ﹤0.01% 1677
2023
Q2 		$3.13M Buy
88,826
+8,220
+10% +$284K ﹤0.01% 1707
2023
Q1 		$2.63M Sell
80,606
-1,027
-1% -$46.8K ﹤0.01% 1751
2022
Q4 		$4.5M Buy
81,633
+2,953
+4% +$162K ﹤0.01% 1456
2022
Q3 		$3.48M Buy
78,680
+18,252
+30% +$890K ﹤0.01% 1568
2022
Q2 		$2.95M Buy
60,428
+8,121
+16% +$366K ﹤0.01% 1687
2022
Q1 		$2.54M Sell
52,307
-322
-0.6% -$13.1K ﹤0.01% 1879
2021
Q4 		$2.25M Buy
52,629
+46,191
+717% +$1.84M ﹤0.01% 1984
2021
Q3 		$246K Buy
6,438
+3,340
+108% +$108K ﹤0.01% 2620
2021
Q2 		$88K Buy
3,098
+2,467
+391% +$74K ﹤0.01% 2779
2021
Q1 		$21K Hold
631
– – ﹤0.01% 3114
2020
Q4 		$23K Buy
+631
New +$25.5K ﹤0.01% 3036

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Legal & General Group's HRMY Position: Q2 2026 in Review

Legal & General Group reduced its Harmony Biosciences (HRMY) stake by 0.91% in Q2 2026, selling an estimated $27.8K and leaving 96,259 shares worth $3.5M. The position accounts for ﹤0.01% of the portfolio, ranked #1737.

Legal & General Group first reported a position in HRMY in Q4 2020 and has held it in 23 quarters since. The position peaked at $4.5M in Q4 2022. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Legal & General Group held 96,259 shares of Harmony Biosciences worth $3.5M as of Q2 2026.
  • Legal & General Group sold 882 Harmony Biosciences shares in Q2 2026, an estimated $27.8K.
  • Harmony Biosciences made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #1737 holding.
  • Legal & General Group first reported a position in Harmony Biosciences in Q4 2020 and has held it in 23 quarters since.
  • Legal & General Group's Harmony Biosciences position peaked at $4.5M in Q4 2022.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.